Profile | GDS5420 / 206668_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 217.89 | 54 |
GSM1296119 | B_lesional_pre-dose | 2076.3 | 90 |
GSM1296076 | C_lesional_pre-dose | 1587.83 | 85 |
GSM1296092 | D_lesional_pre-dose | 1042.63 | 79 |
GSM1296103 | E_lesional_pre-dose | 332.63 | 61 |
GSM1296078 | F_lesional_pre-dose | 1607.02 | 85 |
GSM1296107 | G_lesional_pre-dose | 2183.33 | 90 |
GSM1296109 | H_lesional_pre-dose | 1302.56 | 84 |
GSM1296080 | I_lesional_pre-dose | 273.67 | 58 |
GSM1296090 | J_lesional_pre-dose | 1254.31 | 82 |
GSM1296074 | K_lesional_pre-dose | 1549.88 | 85 |
GSM1296111 | L_lesional_pre-dose | 2508.89 | 92 |
GSM1296099 | M_lesional_pre-dose | 489.89 | 67 |
GSM1296086 | O_lesional_pre-dose | 816.71 | 76 |
GSM1296117 | P_lesional_pre-dose | 2466.04 | 92 |
GSM1296113 | Q_lesional_pre-dose | 2378.17 | 92 |
GSM1296096 | R_lesional_pre-dose | 538.62 | 69 |
GSM1296105 | S_lesional_pre-dose | 426.68 | 65 |
GSM1296098 | T_lesional_pre-dose | 314.72 | 60 |
GSM1296101 | U_lesional_pre-dose | 240.97 | 55 |
GSM1296121 | V_lesional_pre-dose | 1966.53 | 89 |
GSM1296088 | W_lesional_pre-dose | 560.23 | 69 |
GSM1296082 | X_lesional_pre-dose | 1243.89 | 82 |
GSM1296115 | Y_lesional_pre-dose | 2295.54 | 91 |
GSM1296084 | Z_lesional_pre-dose | 511.05 | 68 |
GSM1296072 | B_lesional_day8 | 1465.28 | 85 |
GSM1296069 | L_lesional_day8 | 2000.65 | 90 |
GSM1296071 | P_lesional_day8 | 1677.57 | 88 |
GSM1296070 | Y_lesional_day8 | 2259.38 | 91 |
GSM1296073 | V_lesional_day8 | 2387.13 | 91 |
GSM1296034 | A_lesional_day15 | 142.33 | 46 |
GSM1296041 | G_lesional_day15 | 2711.42 | 92 |
GSM1296035 | R_lesional_day15 | 390.68 | 63 |
GSM1296038 | U_lesional_day15 | 641.62 | 72 |
GSM1296047 | B_lesional_day15 | 1592.49 | 87 |
GSM1296039 | E_lesional_day15 | 898.88 | 78 |
GSM1296042 | H_lesional_day15 | 2330.97 | 91 |
GSM1296043 | L_lesional_day15 | 2200.22 | 91 |
GSM1296037 | M_lesional_day15 | 363.12 | 62 |
GSM1296046 | P_lesional_day15 | 2060.03 | 90 |
GSM1296044 | Q_lesional_day15 | 1898.54 | 89 |
GSM1296045 | Y_lesional_day15 | 2268.07 | 92 |
GSM1296025 | C_lesional_day15 | 435.39 | 65 |
GSM1296033 | D_lesional_day15 | 598.8 | 70 |
GSM1296027 | I_lesional_day15 | 345.06 | 62 |
GSM1296032 | J_lesional_day15 | 716.16 | 73 |
GSM1296024 | K_lesional_day15 | 259.26 | 57 |
GSM1296031 | W_lesional_day15 | 531.14 | 68 |
GSM1296028 | X_lesional_day15 | 611.24 | 71 |
GSM1296029 | Z_lesional_day15 | 480.3 | 67 |
GSM1296026 | F_lesional_day15 | 439.43 | 66 |
GSM1296030 | O_lesional_day15 | 348.84 | 62 |
GSM1296040 | S_lesional_day15 | 195.47 | 52 |
GSM1296036 | T_lesional_day15 | 266.43 | 56 |
GSM1296048 | V_lesional_day15 | 1884.92 | 88 |
GSM1296059 | A_lesional_day43 | 240.59 | 56 |
GSM1296066 | G_lesional_day43 | 2412.5 | 92 |
GSM1296060 | R_lesional_day43 | 456.87 | 66 |
GSM1296063 | U_lesional_day43 | 1055.69 | 80 |
GSM1296064 | E_lesional_day43 | 1299.71 | 83 |
GSM1296067 | H_lesional_day43 | 1148.71 | 82 |
GSM1296062 | M_lesional_day43 | 216.08 | 53 |
GSM1296068 | Q_lesional_day43 | 1835.54 | 89 |
GSM1296050 | C_lesional_day43 | 823.51 | 76 |
GSM1296057 | D_lesional_day43 | 408.33 | 64 |
GSM1296052 | I_lesional_day43 | 389.91 | 64 |
GSM1296054 | J_lesional_day43 | 333.79 | 60 |
GSM1296049 | K_lesional_day43 | 342.18 | 61 |
GSM1296055 | W_lesional_day43 | 589.96 | 70 |
GSM1296053 | X_lesional_day43 | 279.8 | 58 |
GSM1296058 | Z_lesional_day43 | 235.44 | 55 |
GSM1296051 | F_lesional_day43 | 983.79 | 79 |
GSM1296056 | O_lesional_day43 | 420.78 | 65 |
GSM1296065 | S_lesional_day43 | 844.18 | 76 |
GSM1296061 | T_lesional_day43 | 208.13 | 53 |
GSM1296095 | A_non-lesional_pre-dose | 786.57 | 75 |
GSM1296120 | B_non-lesional_pre-dose | 1914.47 | 89 |
GSM1296077 | C_non-lesional_pre-dose | 590.45 | 71 |
GSM1296093 | D_non-lesional_pre-dose | 464.28 | 66 |
GSM1296104 | E_non-lesional_pre-dose | 751.07 | 75 |
GSM1296079 | F_non-lesional_pre-dose | 570.75 | 70 |
GSM1296108 | G_non-lesional_pre-dose | 1915.84 | 89 |
GSM1296110 | H_non-lesional_pre-dose | 1331.69 | 84 |
GSM1296081 | I_non-lesional_pre-dose | 223.14 | 55 |
GSM1296091 | J_non-lesional_pre-dose | 1019.74 | 79 |
GSM1296075 | K_non-lesional_pre-dose | 1315.23 | 83 |
GSM1296112 | L_non-lesional_pre-dose | 1995.14 | 90 |
GSM1296100 | M_non-lesional_pre-dose | 439.39 | 65 |
GSM1296087 | O_non-lesional_pre-dose | 485.8 | 68 |
GSM1296118 | P_non-lesional_pre-dose | 1941.8 | 90 |
GSM1296114 | Q_non-lesional_pre-dose | 2421.14 | 92 |
GSM1296097 | R_non-lesional_pre-dose | 581.28 | 70 |
GSM1296106 | S_non-lesional_pre-dose | 516.76 | 68 |
GSM1296102 | U_non-lesional_pre-dose | 285.41 | 57 |
GSM1296122 | V_non-lesional_pre-dose | 1662.16 | 87 |
GSM1296089 | W_non-lesional_pre-dose | 766.46 | 75 |
GSM1296083 | X_non-lesional_pre-dose | 285.32 | 58 |
GSM1296116 | Y_non-lesional_pre-dose | 2019.99 | 90 |
GSM1296085 | Z_non-lesional_pre-dose | 511.43 | 68 |